Teva Pharmaceutical Industries News

Abbott Laboratories sued Teva Pharmaceutical Industries Ltd., the world's largest generic-drug maker, to prevent it from marketing copies of the Zemplar kidney-disease treatment.

Shares of Momenta Pharmaceuticals Inc. rose Thursday after an analyst upgraded the stock, saying Momenta will soon receive marketing approval for its version of the anti-clotting drug Lovenox.

Israeli stocks traded little changed Wednesday, with gains in a couple of the telecoms and scattered interest in technology stocks offset by weakness in Africa-Israel Investments, Teva Pharmaceutical Industries and Israel Chemicals.

Teva Pharmaceutical Industries Ltd. said Tuesday the Food and Drug Administration approved its generic version of the heartburn drug Prevacid.

Settlements and kickbacks and corporate integrity agreements, oh my To quote the BusinessWeek version of the story: A $112 million settlement involving alleged drug kickbacks that the Justice Dept.

German generic drugmaker Ratiopharm has attracted at least 10 first-round bids, several people familiar with the procedure told Reuters on Wednesday, indicating a competitive auction was underway.

"This is literally a life-and-death issue that must be handled with great care." -- Celgene spokesman Brian Gill, as quoted in The Wall Street Journal .

Will the Israeli government prefer to protect the interests of Teva Pharmaceutical Industries or sacrifice these interests on the alter of the OECD? A document from the OECD Trade Committee reached the Ministry of Industry, Trade and Labor a few days ago; it includes questions about Israel's ideas on intellectual property.

Main Category: Litigation / Medical Malpractice Also Included In: Pharma Industry / Biotech Industry Article Date: 11 Nov 2009 Teva Pharmaceutical Industries Ltd.

JERUSALEM Teva Pharmaceutical Industries has motioned to amend a complaint against two generic drug makers over their alleged infringement of Tevaa s patent on a multiple sclerosis drug.

The route was certainly circuitous but stocks ultimately staged a modest rebound from Friday's ugly action.

Takeda Pharmaceutical Co., Asia's biggest drugmaker, sued Teva Pharmaceutical Industries Ltd., alleging infringement of a U.S. patent for the insomnia treatment Rozerem.

Is this a rare case of Teva Pharmaceutical being forced to swallow its own bitter medicine? The world's largest generic manufacturer, founded on its unflinching willingness to challenge the patented protection of branded products owned by other drugmakers, is suing generic rival Mylan .

Put players pounced on Teva Pharmaceutical Industries Ltd. on Tuesday, after the drug maker stepped into the earnings spotlight.

Pfizer Inc. is wooing up-and-coming Israeli biotech Protalix Biotherapeutics for a possible buyout or partnership, the financial newspaper TheMarker reported Monday.

Omnicare Inc , the largest U.S. provider of pharmacy services to nursing homes, will pay $98 million and Teva subsidiary IVAX Pharmaceuticals will pay $14 million to settle allegations of kickbacks, the U.S. Department of Justice said on Tuesday.

Expeditors International of Washington, Inc , the transportation company reported third quarter revenues fell 33.3% to $1.04 billion from $1.56 billion a year ago.

Israeli stocks fell on Tuesday, with the benchmark index on the verge of closing below 1000 points for the first time in a month, led by weakness in telecom provider Bezeq, while Teva Pharmaceutical slipped after reporting third-quarter earnings.

Teva Pharmaceutical beat earnings expectations with its third-quarter report, although sales fell short of expectations despite a 25% increase.

Main Category: Stem Cell Research Also Included In: Blood / Hematology ; Conferences Article Date: 03 Nov 2009 - 1:00 PST At a symposium today in Herzliya entitled Umbilical Cord Blood: An Alternative for Bone Marrow Transplantation in Adults, bone marrow transplantation experts Professor Patrick Stiff and Professor Guillermo Sanz addressed ...